echo does not require parentheses.Member Portal

Sponsors

Platinum Sponsors

Alexion Pharma Canada

Alexion is focused on providing innovative treatments to patients with severe and life-threatening rare diseases for which there are few, if any, effective treatment options. In 2009, Alexion began operations in Canada to serve patients locally. We aim to work in partnership with all stakeholders including healthcare providers, patient advocacy organizations and government in order to best serve patients. By expanding the knowledge and awareness of rare diseases, we help the medical community improve the process for diagnosis and treatment. Our goal is to bring hope to patients and families by delivering life-changing therapies.

In Canada, Soliris® has received marketing authorization from Health Canada for all patients with PNH. Soliris® is also approved by Health Canada as safe and effective for use in children and adults with atypical HUS to inhibit complement-mediated thrombotic microangiopathy (TMA). To further advance the understanding of PNH and atypical HUS in the Canadian population, Alexion Canada sponsors disease registries that enroll treated and untreated patients who are diagnosed with these conditions. This is our commitment to ongoing research into the rare conditions that our therapies treat.

Learn more about Alexion’s research and development efforts.

argenx Canada Inc.

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker in the U.S., Japan, Israel, the EU, the UK and China. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com

BeiGene Canada

BeiGene Canada is the Canadian affiliate of BeiGene Inc., a global biotechnology company developing and commercializing innovative and affordable cancer medicines to improve treatment outcomes and access for patients worldwide.

Our Mission
Build the first next-generation biotechnology company – one that expands the highest quality medications to more people around the world – through courage, persistent innovation, and challenging the status quo.

Our Vision
Transform the biotechnology industry, creating impactful medicines that will be affordable and accessible to far more cancer patients.

Bruce Power

Bruce Power is an electricity company based in Bruce County, Saugeen Ojibway Nation Territory, Ontario. We are powered by our people. Our 4,200 employees are the foundation of our accomplishments and are proud of the role they play in safely delivering clean, reliable nuclear power to families and businesses across the province and cancer-fighting medical isotopes around the world. Bruce Power has worked hard to build strong roots in Ontario and is committed to protecting the environment and supporting the communities in which we live. Formed in 2001, Bruce Power is a Canadian-owned partnership of TC Energy, OMERS, the Power Workers’ Union and The Society of United Professionals.

Delphic Research

Delphic Research is on a mission to empower government affairs through knowledge. We provide custom tailored executive briefings using our proprietary knowledge engine. Filtered by AI. Curated by people. Insights for clients in the Life Science Sector.

Website: https://www.delphicresearch.ca/  

Contact information: info@delphicresearch.ca 

Innovative Medicines Canada

Innovative Medicines Canada represents Canada’s innovative pharmaceutical industry. We help our members discover, develop, and deliver innovative medicines and vaccines. Our membership consists of 50 companies, from established organizations to fledgling startups, all of whom are revolutionizing healthcare through the discovery and development of new medicines and vaccines. Guided by a strict Code of Ethical Practices, we work with governments, insurance companies, healthcare professionals and stakeholders to advance the field and enhance the wellbeing of Canadians. We are committed to being valued partners in Canada’s healthcare system. We aim to achieve these goals by forming effective alliances, supporting policies, improving Canada’s regulatory environment, widening access to innovative medicines and ensuring the effective protection of intellectual property. We believe in ensuring that Canadians have access to the innovative treatments they need and that our activities are a fundamental part of safeguarding our healthcare system for future generations. Our work allows our members to focus on what matters: delivering better healthcare solutions to Canadians.

 Johnson & Johnson, Family of Companies in Canada

As part of the world’s largest and most broadly-based healthcare company (comprised of Consumer Health, Pharmaceuticals and Medical Devices), we are committed to using our reach and size for good every day.

McKesson Canada

McKesson Canada is in the business of better health. For over 100 years, we have been partnering with key players in the Canadian health care industry, and working every day to create a more efficient system and building healthier communities from coast-to-coast.

We’re experiencing an era of unprecedented change in health care. New technology, new services and new ideas will be needed to deliver improved outcomes for businesses and patients. McKesson is at the forefront of that transformation.

We partner with key players in the health care industry to build healthier organizations that deliver better care to patients in every setting.

We form essential connections that make health care smarter, creating intelligent networks that expand access, reduce waste, and bring people and information closer together.

We supply the industry with the resources, support and technology it needs to create new standards and a world of better health.

Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Sanofi Canada

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. Sanofi entities in Canada employ approximately 1,900 people. In 2017 we invested over $123 million in R&D in Canada, creating jobs, business and opportunity throughout the country. Sanofi, Empowering Life.

Shift Health

Shift Health brings a science mindset to strategy consulting for the health research and innovation ecosystem.

We blend scientific depth, sector leadership and global perspective, tackling our clients’ most challenging questions with curiosity, rigour and courage.

Delivering sharp insights and customized solutions, we’re helping to create the future of healthcare.

Gold Sponsors

adMare BioInnovations

With a wealth of scientific discovery, Canada is primed to be a global leader in life sciences. To realize this potential, adMare uses its scientific and commercial expertise, specialized R&D infrastructure, and investment capital to build investable companies, robust ecosystems and industry-ready talent – and re-invests its returns back into the Canadian industry to ensure it is sustained for the long-term.

BD Canada

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.

BioTalent Canada

BioTalent Canada™ is the catalyst for significant and sustainable growth in Canada’s bio-economy. We’re the HR partner of employers, associations, academia, immigrant serving agencies and service providers in this rapidly evolving sector. Our success is deeply rooted in current, reliable labour market data that helps industry recruit, train and retain the best and brightest. Our dynamic programs remain aligned with government priorities and connect job-ready talent to industry.

Recently named one of the 50 Best Workplaces in Canada with 10-50 employees and awarded a Great Place to Work® Certification 2021, BioTalent Canada practices the same industry standards it recommends to its stakeholders. These distinctions were awarded to BioTalent Canada following a thorough and independent analysis conducted by Great Place to Work®.

Stryker 

Stryker is one of the world’s leading medical technology companies and, together with our customers, is driven to make healthcare better. We offer innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

Taiho Pharma Canada Inc.

Taiho Pharma Canada, Inc., a Canadian subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), is located in Oakville, Ontario and managed by Taiho Oncology based in Princeton, New Jersey. Taiho Pharma’s mission in Canada is to lead oncology innovation, drive research and transform the lives of Canadians living with cancer.  Taiho Oncology has established world class clinical development and commercial organizations that work urgently to develop and market innovative cancer treatments.  Taiho Oncology Inc. has an oral oncology pipeline consisting of both novel anti-metabolic agents and selectively targeted agents. Advanced technology, dedicated researchers, and state of the art facilities are helping Taiho define the way the world treats cancer. It’s our work; it’s our passion; it’s our legacy.

Silver Sponsors

Astellas Pharma Canada, Inc

Astellas Pharma Canada, Inc. is a Canadian affiliate of Tokyo-based Astellas Pharma Inc., a pharmaceutical company conducting business in more than 70 countries around the world. Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people in Canada and around the world.

BDO Canada

Exceptional service begins with exceptional relationships. The best reason to choose BDO isn’t our service offerings, though they are among the most extensive in our industry. It isn’t our resources, though they are among the broadest in the world. It isn’t that we possess experience working with virtually every business sector in Canada, or that we offer the highest standards of technical excellence, though we do. Ultimately, the best reason to choose BDO comes down to the relationships we build with our clients and communities.  Because at the end of the day, ours is a business of people working with, for, and in the service of others. And when you think about it that way, client service becomes more than just client service; it becomes a firm-wide dedication to helping the people we serve succeed – whatever they need, wherever they are, however we can.

Eisai Limited

At Eisai, everything we do is guided by a simple, yet transformative principle: patients and their families come first and we have a responsibility to listen to and learn from them. We call this human health care or hhc.

We give our first thoughts to patients and their families, and to helping increase the benefits health care provides. Everyone at Eisai spends at least two to three days each year directly interacting with patients and learning about their experiences.

Ernst & Young LLP

At EY, we are committed to building a better working world — with increased trust and confidence in business, sustainable growth, development of talent in all its forms, and greater collaboration. We want to build a better working world through our own actions and by engaging with like-minded organizations and individuals. This is our purpose — and why we exist as an organization. Running through our organization is a strong sense of obligation to serve a number of different stakeholders who count on us to deliver quality and excellence in everything we do. We want to use our global reach and scale to convene the conversation about the challenges facing economies and the capital markets. When business works better, the world works better. Learn more about our commitment to building a better working world.

Innomar Strategies, Inc.

Since 2001, we have provided an unparalleled balance between patient care and market access, and continue to deliver innovative solutions to specialty manufacturers to improve product access, increase supply chain efficiency, and ultimately enhance patient care.

Niagara Region

Niagara, Canada is open for business and the Niagara Economic Development team offers concierge-style support to businesses that are considering investment in the region. Whether you are an established Niagara business looking to expand, or a business from outside the region researching Niagara as a potential location for future investment, the Niagara Economic Development team can connect you with information, contacts, and referrals to numerous programs, incentives and services to help your business prosper.

Learn more about the free and confidential services available for your business.

University of Toronto Arts & Science Co-op

Simplify your recruiting process by partnering with the University of Toronto Arts & Science Co-op program.  We offer the unique option of 4, 8 or 12-month work terms, allowing you to choose the duration that best suits your organization’s projects and needs. Students are available year-round from 35 programs including our top-ranked Biochemistry, Chemistry, Molecular Biology and Biotechnology,  Neuroscience and Computer Science programs.

Our recruiting process is simple: recruit according to your timelines and make offers to your chosen candidate – we’ll handle the rest.  From posting to hiring, we can help you find a great fit in as few as 10 days.

For more information click here.